Gougeon M, Seffer V, Hoxha C, Maillart E, Popoff M
Toxins (Basel). 2025; 17(1).
PMID: 39852980
PMC: 11768822.
DOI: 10.3390/toxins17010027.
Dorca-Arevalo J, Santana-Ruiz A, Torrejon-Escribano B, Martin-Satue M, Blasi J
Toxins (Basel). 2024; 16(12.
PMID: 39728783
PMC: 11728497.
DOI: 10.3390/toxins16120525.
Cases M, Dorca-Arevalo J, Blanch M, Rodil S, Terni B, Martin-Satue M
Pharmacol Res Perspect. 2024; 12(5):e70005.
PMID: 39320019
PMC: 11423345.
DOI: 10.1002/prp2.70005.
Liu Z, Mou S, Li L, Chen Q, Yang R, Guo S
Cells. 2024; 13(13.
PMID: 38994991
PMC: 11240805.
DOI: 10.3390/cells13131140.
Titball R
Toxins (Basel). 2024; 16(4).
PMID: 38668605
PMC: 11053738.
DOI: 10.3390/toxins16040180.
Epsilon Toxin Binds to and Kills Primary Human Lymphocytes.
Shetty S, Mazzucco M, Winokur P, Haigh S, Rumah K, Fischetti V
Toxins (Basel). 2023; 15(7).
PMID: 37505692
PMC: 10467094.
DOI: 10.3390/toxins15070423.
Is epsilon toxin associated with multiple sclerosis?.
Titball R, Lewis N, Nicholas R
Mult Scler. 2023; 29(9):1057-1063.
PMID: 37480283
PMC: 10413780.
DOI: 10.1177/13524585231186899.
Statins as Potential Preventative Treatment of ETX and Multiple Pore-Forming Toxin-Induced Diseases.
Huang J, Zhao B, Liu T, Kang L, Li J, Guo Z
Int J Mol Sci. 2023; 24(6).
PMID: 36982489
PMC: 10048941.
DOI: 10.3390/ijms24065414.
Systematic evaluation of membrane-camouflaged nanoparticles in neutralizing Clostridium perfringens ε-toxin.
Xu J, Li D, Kang L, Liu T, Huang J, Li J
J Nanobiotechnology. 2023; 21(1):95.
PMID: 36932366
PMC: 10021051.
DOI: 10.1186/s12951-023-01852-z.
Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.
Ma Y, Sannino D, Linden J, Haigh S, Zhao B, Grigg J
J Clin Invest. 2023; 133(9).
PMID: 36853799
PMC: 10145940.
DOI: 10.1172/JCI163239.
Interaction of Epsilon Toxin with the Plasma Membrane: The Role of Amino Acids Y42, Y43 and H162.
Marshall S, McGill B, Morcrette H, Winlove C, Chimerel C, Petrov P
Toxins (Basel). 2022; 14(11).
PMID: 36356007
PMC: 9694948.
DOI: 10.3390/toxins14110757.
New Mutants of Epsilon Toxin from with an Altered Receptor-Binding Site and Cell-Type Specificity.
Dorca-Arevalo J, Gomez de Aranda I, Blasi J
Toxins (Basel). 2022; 14(4).
PMID: 35448898
PMC: 9031233.
DOI: 10.3390/toxins14040288.
Bacterial pore-forming toxins.
Ulhuq F, Mariano G
Microbiology (Reading). 2022; 168(3).
PMID: 35333704
PMC: 9558359.
DOI: 10.1099/mic.0.001154.
Cell death analysis of recombinant mature epsilon toxin on the kidney cell line.
Chehreara R, Karizi S, Mahmoodzadeh Hosseini H, Mirhosseini S, Shafiei M, Amani J
Iran J Microbiol. 2022; 13(6):832-838.
PMID: 35222862
PMC: 8816699.
DOI: 10.18502/ijm.v13i6.8088.
CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis.
Mazzucco M, Mannheim W, Shetty S, Linden J
Fluids Barriers CNS. 2022; 19(1):13.
PMID: 35135557
PMC: 8822708.
DOI: 10.1186/s12987-021-00299-4.
The MAL Protein, an Integral Component of Specialized Membranes, in Normal Cells and Cancer.
Rubio-Ramos A, Labat-de-Hoz L, Correas I, Alonso M
Cells. 2021; 10(5).
PMID: 33946345
PMC: 8145151.
DOI: 10.3390/cells10051065.
Clostridium perfringens epsilon toxin binds to erythrocyte MAL receptors and triggers phosphatidylserine exposure.
Geng Z, Huang J, Kang L, Gao S, Yuan Y, Li Y
J Cell Mol Med. 2020; 24(13):7341-7352.
PMID: 32463157
PMC: 7339222.
DOI: 10.1111/jcmm.15315.
Lung endothelial cells are sensitive to epsilon toxin from Clostridium perfringens.
Dorca-Arevalo J, Dorca E, Torrejon-Escribano B, Blanch M, Martin-Satue M, Blasi J
Vet Res. 2020; 51(1):27.
PMID: 32093740
PMC: 7041264.
DOI: 10.1186/s13567-020-00748-2.
Herpes Simplex Virus 1 Spread in Oligodendrocytic Cells Is Highly Dependent on MAL Proteolipid.
Lopez-Guerrero J, de la Nuez C, Praena B, Sanchez-Leon E, Krummenacher C, Bello-Morales R
J Virol. 2019; 94(4).
PMID: 31748392
PMC: 6997773.
DOI: 10.1128/JVI.01739-19.
Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL.
Linden J, Flores C, Schmidt E, Uzal F, Michel A, Valenzuela M
PLoS Pathog. 2019; 15(11):e1008014.
PMID: 31703116
PMC: 6867657.
DOI: 10.1371/journal.ppat.1008014.